Quantitative measurement of total and free 3‐hydroxy fatty acids in serum or plasma samples: short‐chain 3‐hydroxy fatty acids are not esterified
Authors:
- 1 November 2000
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 23 (7) , 745-750
Abstract
Diagnostic protocols for disorders of mitochondrial fatty acid oxidation (FAO) generally include the measurement of plasma acylcarnitines. Many biochemical intermediates of FAO resulting from a metabolic block require carnitine conjugation for transport out of the mitochondria, and so occur as fatty acid–carnitine conjugates in the blood. Both short‐ and long‐chain acylcarnitines are generally determined, and this procedure has a critical role to play in the diagnosis of disorders of the very long‐chain, medium‐chain and short‐chain acyl‐CoA dehydrogenase defects. Less is known about the utility of acylcarnitines for the measurement of the various chain length intermediates of the 3‐hydroxyacyl‐CoA dehydrogenase steps of β‐oxidation. This study utilizes stable‐isotope dilution gas chromatography–mass spectrometry to determine the serum or plasma concentrations of free 3‐hydroxy fatty acids (3‐OHFAs) of chain lengths C6 to C16. The 3‐OHFA concentrations are determined in samples from normal individuals, hyperketotic individuals and patients with long‐chain L‐3‐hydroxyacyl‐CoA dehydrogenase and short‐chain L‐3‐hydroxyacyl‐CoA dehydrogenase deficiencies, both before and after hydrolysis. The results of the study indicate the relative amounts of conjugated intermediates of all chain lengths. Long‐chain 3‐OHFAs (C14 and C16) are found in elevated concentrations after hydrolysis, whereas short‐chain and medium‐chain 3‐OHFAs (C6 to C12) show no difference in concentrations between the two samples in all subjects tested, suggesting that only long‐chain 3‐hydroxy species form conjugates. This finding has important implications for the use of the acylcarnitine assay for the diagnosis of defects involving short‐chain and medium‐chain 3‐hydroxy fatty acids.Keywords
This publication has 14 references indexed in Scilit:
- Fatal Hepatic Short-Chain l-3-Hydroxyacyl-Coenzyme a Dehydrogenase Deficiency: Clinical, Biochemical, and Pathological Studies on Three Subjects with This Recently Identified Disorder of Mitochondrial β-OxidationPediatric and Developmental Pathology, 1999
- Medium Chain 3-Ketoacyl-Coenzyme A Thiolase Deficiency: A New Disorder of Mitochondrial Fatty Acid β-OxidationPediatric Research, 1997
- Long-chain 3-hydroxyacyl–coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of thirteen patientsThe Journal of Pediatrics, 1997
- Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.Journal of Clinical Investigation, 1996
- Mitochondrial Short-Chain L-3-Hydroxyacl-Coenzyme A Dehydrogenase Deficiency: A New Defect of Fatty Acid OxidationPediatric Research, 1996
- Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.Proceedings of the National Academy of Sciences, 1995
- Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency.Journal of Clinical Investigation, 1995
- The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.Proceedings of the National Academy of Sciences, 1995
- Fatty acid oxidation disorders: A new class of metabolic diseasesThe Journal of Pediatrics, 1992
- The Laboratory Diagnosis of Inborn Errors of Mitochondrial Fatty Acid OxidationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990